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Figure S1 (Related to Figure 1): The effect of VDAC1 or Tom40 on mitochondrial morphology.  
(A-B) Control and shSam50 HeLa cells were subjected to immunoblot for Sam50 and Tubulin (A). 
Quantification of the relative Sam50 levels by densitometry analysis using ImageJ software (B). Error bars 
indicate the mean ±SD of three independent experiments, ***P < 0.0001. 
(C-D) The mitochondrial morphology of shSam50 HeLa cells expressing mito-DsRed at the indicated time was 
visualized by confocal microscope (C). The level of Sam50 was measured by immunoblotting (D). 
(E) HeLa cells expressing Myc-Sam50 (mouse Sam50) were infected with control or shSam50 lentiviral 
particles, the cell lysates were subjected to immunoblot using the indicated antibodies. 
(F) Sam50flox/flox MEFs were infected with control or Cre retroviral particles and cultured for 10 days. The whole 
cell lysates were evaluated by immunoblot analysis using Sam50 antibody. 
(G-H) The level of Metaxin1 and Metaxin2 were analyzed by immunoblot analysis using the indicated 
antibodies. 
(I-K) Mitochondrial morphology in control or shTom40 HeLa cells expressing mito-DsRed were visualized by 
confocal microscope (I), then was counted according to the criteria detailed in “Experimental Procedures” (K). 
Data are expressed as means ± SD. The effect of Tom40 knockdown was analyzed by immunoblot using 
anti-Tom40 and anti-Tubulin antibodies (J). 
(L-M) Mitochondrial morphology of control and shVDAC1 HeLa cells was counted according to the criteria 
detailed in “Experimental Procedures”. Error bars represent means ± SD of three independent experiments (L). 
The level of VDAC1 was analyzed by immunoblot using anti-VDAC1 antibody (M). 
(N) Control or shSam50 HeLa cells were cultured continuously for 10 days, mitochondria in cells expressing 
mito-GFP (green) were immunostained for OMP25 (red, anti-OMP25), the images were acquired with a 
super-resolution structured illumination microscopy. The arrow indicates the large spherical mitochondrion. 
(O) The protein levels of MICOS complex components in control or shSam50 (5 or 10days) HeLa cells were 
analyzed by immunoblotting with the indicated antibodies. 
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Figure S2 (Related to Figure 2): The role of mitochondrial fusion or fission factors in shSam50 induced 
abnormal mitochondrial morphology.  
(A) The protein levels of fusion and fission factors in control or shSam50 (5days) HeLa cells were further 
evaluated by densitometry analysis using ImageJ software. Error bars indicate the mean ±SD of three 
independent experiments, #P<0.05. 
(B) The ratio of Short isoforms / Long isoforms of OPA1 was quantified in control or shSam50 (5 days) HeLa 
cells. Error bars indicate the mean ±SD of three independent experiments, **P<0.001. 
(C-D) Control or shSam50 (5 days) HeLa cells were fractionated into cytosolic and mitochondrial fractions, then 
evaluated by immunoblot analysis as indicated. The level of Drp1 in mitochondria was then quantified (D). 
(E) Control or shSam50 (5 days) HeLa cells were immunoblotting using the indicated antibodies. 
(F-H) the mitochondrial morphology of control, shSam50 (5 days), shSam50 (5 days) plus Flag-Mfn1, or 
shsam50 (5 days) plus Myc-Mfn2 HeLa cells was visualized by confocal microscope (F), then was counted 
according to the criteria detailed in “Experimental Procedures” (G). Data are expressed as means ± SD,*P<0.01. 
The protein levels of Mfn1, Mfn2 and Sam50 were analyzed by immunoblotting using the indicated antibodies 
(H). 
(I) WT, Mfn DKO or OPA1 KO MEFs cells expressing mito-DsRed were infected with control or shSam50 
lentiviral particles and cultured for 10 days, then the whole cell lysates were evaluated by immunoblot analysis 
using the indicated antibodies. 
(J-K) control or shSam50 (5 days) HeLa cells lysates were used for co-immunoprecipitation assay by anti-Mfn2 
antibody, and the eluted protein samples were analyzed by immunoblotting with anti-Mfn2 and anti-Mfn1 
antibodies (J). The relative ratio of Mfn1/Mfn2 was quantified (K). Error bars indicate the mean ±SD of three 
independent experiments, **P<0.001. 
(L-M) Control or shSam50(5d) HeLa cells expressing Myc-Mfn2 lysates were used for co-immunoprecipitation 
assay by anti-Myc antibody, and the eluted protein samples were analyzed by immunoblotting with anti-Mfn2 
antibody (L). The relative ratio of Mfn2/Myc-Mfn2 was quantified (M). Error bars indicate the mean ±SD of 
three independent experiments **P<0.001. 
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Figure S3 (Related to Figure 3): The effect of Sam50 knockdown in mitochondrial ATP or ROS 
production. 
(A) Relative ATP levels of control or shSam50 HeLa cells were measured using an ATP assay kit. Bars represent 
means ± SD of three independent experiments. 
(B) Cell lysates of control or shSam50 (5 days) HeLa cells were measured by immunoblot analysis using the 
indicated antibodies. 
(C and D) Control or shSam50 were HeLa cells were stained with MitoSox, cells were then visualized by 
confocal microscopy (C). The fluorescence intensity was further analyzed by ImageJ software (D). Bars 
represent means± SD of three independent experiments. 
(E) The relative cell growth rate of control or shSam50 HeLa cells were measured by a cell counting kit (CCK-8). 
Bars represent means ± SD of three independent experiments. 
(F-G) The percentage of cell death of control or shSam50 (5, 7, and 10 days) HeLa cells were quantified (F), 
bars represent means ± SD of three independent experiments. PARP and cleaved caspase-3 in cells described in 
“F” were measured by immunoblot analysis (G), and cells treated with actinomycin D (Act-D) acted as a 
positive control for apoptosis. 
(H) Flow cytometry analysis of cell cycle in control or shSam50 (5, 7, and 10 days) HeLa cells (a). Immunoblot 
analysis of the protein level of Sam50 (b). 
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Figure S4 (Related to Figures 3 and 4): Sam50 knockdown induces mitophagy in some other cell lines. 
(A-F) H1299 (A and B), A549 (C and D), and HCT116 (E and F) cells were infected with control or shSam50 
lentiviral particles, cells were immunostained for HSP60. Mitochondrial morphology was visualized by confocal 
microscope. Cell lysates were subjected to immunoblot using the indicated antibodies. Nuclear-targeted GFP 
contained cells indicates shSam50 cells. 
(G) Control or shATG5 HCT116 cells were infected with control or shSam50 lentiviral particles and then 
cultured for 10 days, cells lysates were then assessed by immunoblot using the indicated antibodies. 
(H) HCT116 cells with or without a shATG7 background were infected with control or shSam50 lentiviral 
particles and then cultured for 10 days, cell lysates were evaluated by immunoblot analysis as indicated. 
(I) control or shSam50 HCT116 cells were cultured for 6 days, then with or without 200nM BFA treatment for 
72h. Cell lysates were evaluated by immunoblot analysis as indicated. 
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Figure S5 (Related to Figures 4 and 6): The effect of Sam50 knockdown on mitochondrial membrane 
potential. 
(A) Control or PINK1 KO HeLa cells were treated with CCCP (10 µM, 2h), and then subjected to immunoblot 
using anti-PINK1 or anti-Actin antibody. 
(B) Sam50 in control or GFP-Parkin expressed HeLa cells were knocked down for 10 days, the mitochondrial 
mass was evaluated by immunostaining for cytochrome c (Cyto c). “C” indicates “control cells”, and “G-P” 
indicate“GFP-Parkin expressed cells”. 
(C-G) HeLa cells expressing GFP-parkin were infected with control, shTom40 (C), or shTom40 plus shATG5 
(C), shVDAC1 (D), shMetaxin1 (E), shMetaxin2 (F), shMic60 (G) lentiviral particles and then cultured for 5 or 
10 days, cell lysates were subjected to immunoblot using the indicated antibodies. 
(H) HeLa cells stably expressing GFP-Parkin were infected with control or shTom40 lentiviral particles for 5 or 
10 days (most cells were died in 10 days), and then were immunostained with anti-Tom20 antibody. Localization 
of GFP-Parkin was visualized by confocal microscope. 
(I) Control or shSam50 HeLa cells with or without CCCP (10 µM, 1h) treatment were incubated with a 
mitochondrial membrane potential-dependent dye, TMRM (tetramethylrhodamine methyl ester, 600 nM, 25 min), 
and washed extensively. Live fluorescent images were obtained by confocal microscope.  
(J-L) HeLa cells (J), HCT116 cells (K) or A549 cells (L) were infected with control or shSam50 lentiviral 
particles, and cultured for 10 days, then treated with or without CCCP (10 µM, 4h) and incubated with TMRM 
(600 nM, 25 min), then analyzed by flow cytometry. Bars represent means± SD of three independent 
experiments. “N.S.”represent “not significant”. 
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Figure S6 (Related to Figure 4): shSam50-induced mitochondrial fragmentation is independent on 
PINK1-Parkin. 
(A-D) PINK1 knockout (KO) HeLa cells or Parkin knockout (KO) MEFs were infected with control or shSam50 
lentiviral particles for 5 or 10 days, cells were immunostained with the indicated antibodies. Mitochondrial 
morphology was visualized by confocal microscopy (A and C), and was counted according to the criteria 
detailed in “Experimental Procedures”. Bars represent means ± SD of triplicate counts of 100 cells (B and D). 
(E-G) Control or shDrp1 HeLa cells expressing mito-DsRed were further infected with shSam50 lentiviral 
particles for additional 5 days. The mitochondrial morphology was visualized by confocal microscopy (E), and 
were counted according to the criteria detailed in “Experimental Procedures” (G), data are expressed as means ± 
SD, *P<0.01. The levels of Drp1 and Sam50 was analyzed by immunoblotting (F). 
(H) Control or shDrp1 HeLa cells were further infected with shSam50 lentiviral particles for additional 10 days. 
Whole-cell lysates were analyzed by immunoblotting using the indicated antibodies. 
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Figure S7 (Related to Figures 1 and 7): The role of Sam50 in the distribution of mtDNA nucleoids and the 
function of gop3 in C. elegans. 
(A-B) Control or shSam50 HeLa cells expressing mito-DsRed were stained with SYBR green I. The morphology 
of mtDNA nucleoids was visualized by confocal microscope (A), cells containing nuclear-targeted GFP indicates 
shSam50 cells. The average number of mtDNA nucleoid per cell and average diameter of nucleoid were 
analyzed and quantified (B). 30 randomly selected cells were counted and analyzed. The data represent the 
means ± SD of three independent experiments. 
(C) Control or shSam50 HeLa cells stably expressing mito-GFP were immunostained with an antibody against 
SSBP1. Morphology of mtDNA nucleoids was analyzed by confocal microscope. 
(D-E) Wild type (WT) and gop-3 mutant C. elegans were observed by DIC microscope (D). The percentage of 
growth defects was quantified. n=3 (100 worms per independent experiment), Data are expressed as means ± SD, 
**P<0.001 (E). 
(F-G) Mitochondrial morphology in WT or gop-3 mutant C. elegans was visualized by confocal microscope (F). 
Mitochondrial morphology was quantified. The data represent the means ± SD of three independent experiments 
(100 mitochondria was randomly selected per worm), ***P<0.0001 (G). 
(H) Lysates of WT and gop-3 mutant C. elegans were subjected to immunoblot using the indicated antibodies. 
(I) mtDNA contents of WT or gop-3 mutant C. elegans were quantified and normalized to nDNA. The data 
represent the means ± SD of three independent experiments. “N.S.” indicates “not significant”. 
 
ADDITIONAL MATERIALS AND METHODS 
 
Cell culture, Antibodies and Reagents  
HeLa, A549, H1299, HCT116, 143B, 143B rho0 cells and MEFs were cultured in Dulbecco’s modified Eagle’s 
medium (Gibco) supplemented with 10% FBS (PAN, Germany)，1% Penicillin/Streptamycin (Gibco) and 1% L-
glutamine at 37°C with 5%CO2, 143B rho0 are incubated with medium adding uridine (50µg/ml, Sigma Aldrich). 
Antibodies were used in this study: anti-Cox4, anti-Mff, anti-Tom20, anti-p62, anti-Tom40, anti-Metaxin-2, anti-
Prohibitin-2, anti-Twinkle, and anti-TFAM ,anti-Syntaxin17, anti-MPPβ, anti-Mid49， anti-Mid51, anti-GM130, 
anti-Mic60, anti-Lon, anti-CLPP, anti-Afg3L2 and anti-OMP25 were purchased from Proteintech; anti-Cox2, anti-
Mfn1, anti-Mfn2, anti-VDAC1, anti-POLG, and anti-Sam50 were from Abcam; anti-ATG5, anti-Dynamin2 and 
anti-Mic19 were from ABclonal; anti-LAMP1, anti-PARP, anti-PGC-1α, anti-GFP, anti-cytochrome c, and anti-
HSP60 were from Santa Cruz Biotechnology; anti-PINK1 was from Novus Biologicals; anti-PMP70 was from 
Life technologies; anti-Mic10 was from Origene; anti-Drp1 and anti-OPA1 were purchased from BD Biosciences; 
anti-LC3 and anti-Flag was from Sigma-Aldrich; mouse monoclonal anti-DNA was from Progen; anti-Phospho-
ULK1(Ser317), anti-ULK1, anti-ATG7, anti-Phospho-DRP1(Ser637), anti-Phospho-DRP1(616), anti-EEA1 and 
anti-cleaved Caspase-3 were purchased from Cell Signaling. Reagents used in this paper were: Carbonyl cyanide 
3-chlorophenylhydrazone (CCCP, Sigma-Aldrich), oligomycin and antimycin-A (Sigma-Aldrich); actinomycin D 
(Abcam); SYBR Green I was purchased from Molecular Probes. Lipofectamine 2000 and Opti-MEM I (Invitrogen, 
Carlsbad, CA, USA). 
 
Plasmids and shRNA construction 
shRNAi against Sam50 was performed using a modified retroviral vector with the H1 promoter to drive the 
expression of shRNAs (Chen et al., 2005). The target sequences of shRNAi oligonucleotides were listed in “Table 
S1”. GFP-Parkin, PINK1-GFP, Flag-Sam50, Myc-Sam50，and GFP-LC3 cDNA were cloned into pMSCV-puro 
or pHAGE constructs. 
 
Immunoblot and Co-immunoprecipitation Assay 
Whole-cell lysates were prepared with SDS-PAGE sample buffer. Samples were boiled for 10min, and then 
separated by SDS–PAGE and electrophoretically transferred onto a nitrocellulose membrane. After blocking with 
5% nonfat milk in TBST, membrane was incubated with the primary antibodies, followed by HRP-conjugated goat 
anti-rabbit or anti-mouse IgG. Co-immunopricipitaion was performed as we have described previously (Li et al., 
2016), and then the samples were analyzed by immunoblot as above described. 
 Photoactivatible GFP Assay 
Mitochondrial targeted DesRed (mito-DsRed) and photoactivatible GFP (PA-GFP) targeted to mitochondrial 
matrix (mito-PA-GFP) were stably expressed in cells and performed PA-GFP assay. Within a single cell, a small 
subset of mitochondria were photoactivated by excitation at 405nm, and then the mitochondrial fusion and fission 
events were tracked by time-lapse microscopy for about 20 min. 
 
Measurement of ATP Production. 
Cellular ATP levels were measured using an ATP assay kit (Celltiter-Glo Luminescent Cell Viability Assay, 
Promega) according to the manufacturer’s instructions. Luminescence was measured using microplate reader and 
the values were normalized to the protein concentration. 
 
Measurement of Mitochondrial Membrane Potential 
Cells in 6-well plates were collected and washed with PBS, and then cells were incubated at 37°C under 5% CO2 
with 600nM TMRM in DMEM without FBS for 25 minutes. Cells washed three times and analyzed by FACS. 
Cells were treated with Carbonyl cyanide 3-chlorophenylhydrazone (CCCP) as a positive control. 
 
Mitochondrial ROS Measurement  
Mitochondrial ROS was detected by MitoSOXTM Red (Invitrogen) according to the manufacturer’s instructions. 
Briefly, cells were incubated with 5uM MitoSOX with Hank’s balanced salt solution at 37°C for 15min, then 
washed cells 3 times with HBSS solution with Ca2+ and Mg2+ (1.26mM CaCl2, 0.5mM MgCl2, 0.4mM MgSO4, 
5.33mM KCl, 0.44 KH2PO4, 4.16mM NaHCO3, 138mM NaCl, 0.34mM Na2HPO4 and 5.56mM D-Glucose). The 
fluorescence was measured qualitatively by confocal microscopy under excitation at 510nm, and the emission was 
collected at 580nm. The fluorescence intensity was analyzed by using LAS AF lite software. 
 
Cell Cycle Analysis 
Cell cycle was analyzed by flow cytometry. Cells were collected and washed with PBS, then cells were fixed with 
70% ethanol overnight at 4 °C. The fixed cells were centrifuged at 800 g at 25 °C for 5 min, the supernatant was 
removed, and the cells were washed with PBS. Then, cells were stained with 4 μl of 10 mg/ml propidium iodide 
(PI) and 10 μl of 1 mg/ml RNase in 400 μl PBS, followed by incubation in the dark for 30 min at 4 °C prior to 
measurement of the stained cells on a flow cytometer (Beckman, Indianapolis, CA, USA). The results were 
analyzed using FlowJo software (Tree Star, San Carlos, USA). 
 Cell Proliferation and Cell Death Assay 
Cell proliferation was measured using a Cell Counting Kit (CCK-8) according to the manufacturer’s instructions. 
The absorbance of the control and shSam50 cells was measured with microplate reader at 450nm. For the cell 
death assay, a 10μl aliquot of cell suspension was incubated with 10μl of 0.4% trypan blue solution for 5 minutes 
at room temperature. Viable and nonviable cells based on absence and presence of intracellular trypan blue dye, 
respectively. Cells were counted by the hemacytometer. 
 
Mito-Keima Mitophagy Assay 
HeLa cells expressing Flag-Parkin were infected with a lentivirus harboring the mito-keima vector (a gift from 
Michael Lenard), and grown for several days. control, shSam50 or OA treated cells stably expressing Flag-Parkin 
plus mito-Keima were trypsinized, washed once with PBS buffer and then resuspended in sorting buffer (145mM 
NaCl, 5mM KCl, 1.8mM CaCl2, 0.8mM MgCl2, 10mM HEPES,10mM Glucose, 0.1% BSA), and analyzed by a 
BD flow cell sorter. Measurements of lysosomal mito-Keima were made using dual-excitation ratiometric pH 
measurements at 488 (pH 7) and 561 (pH 4) nm lasers with 620/29 nm and 614/20 nm emission filters, respectively. 
For each sample, 20,000 events were collected. Data were analyzed using FlowJo (Tree Star, San Carlos, USA). 
 
EM Studies  
HeLa cells were fixed and prepared as we have described previously (Li et al., 2016). The stained sections were 
imaged onto negatives using a Jeol electron microscope (Joel Ltd, Tokyo, Japan) operated at 80 kV. 
 
Mitochondrial DNA content quantiﬁcation. 
DNA from HeLa cells was extracted using the gDNA Kit (BioMIGA) according to the manufacturer’s instructions. 
The LightCycler 480 SYBR Green I master (RoChe) was used for quantitative PCR with an ABI PRISM 7000 
Sequence Detector System (Applied Biosystems). The primer sets for amplification of mtDNA and β-globin 
nuclear DNA fragments were used as described previously (Miller et al., 2003). mtDNA contents were calculated 
by using nuclear DNA content as a reference. 
Plasmids and C. elegans CRISPR/Cas9 strains heat-shock treatment 
All strains were raised at 20°C on nematode growth medium (NGM) plates seeded with the Escherichia coli strain 
OP50. Three CRISPR/Cas9 and sgRNA plasmids (50 ng/μl) were injected into hermaphrodites using the selection 
marker Podr-1::dsRed to generate the triple conditional knockouts. 50 transgenic adult worms were placed on a 
seeded NGM plate to lay eggs for 4 hours, and removed adult worms. After that, the eggs were heat-shocked at 
31°C for 1 hour and then cultured at 20°C until the adult stage.  
 
REFERENCES 
Chen H, Chomyn A, Chan DC (2005) Disruption of fusion results in mitochondrial heterogeneity and dysfunction. 
The Journal of biological chemistry 280: 26185-92 
Li H, Ruan Y, Zhang K, Jian F, Hu C, Miao L, Gong L, Sun L, Zhang X, Chen S, Chen H, Liu D, Song Z (2016) 
Mic60/Mitofilin determines MICOS assembly essential for mitochondrial dynamics and mtDNA nucleoid 
organization. Cell death and differentiation 23: 380-92 
Miller FJ, Rosenfeldt FL, Zhang C, Linnane AW, Nagley P (2003) Precise determination of mitochondrial DNA 
copy number in human skeletal and cardiac muscle by a PCR-based assay: lack of change of copy number with 
age. Nucleic acids research 31: e61 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SUPPLEMENTAL EXPERIMENTAL TABLE 
Table S1 (Related to Figures 1-7). List of primers for construction of shRNAi plasmids.  
Target gene Oligonucleotide sequence 
Homo Sam50 
(shSam50-A) 
F 5′-GATCCCCGGTCATCGATTCTCGGAATTTCAAGAGAATTCCGAGAATCGA 
TGACCTTTTTGGAAA-3′ 
R 5′-AGCTTTTCCAAAAAGGTCATCGATTCTCGGAATTCTCTTGAAATTCCGAGA 
ATCGATGACCGGG-3′ 
Homo Sam50 
(shSam50-B) 
F 5′-CCGGGGACATTCACTGAAATCATCTCTCGAGAGATGATTTCAGTGAATGTCC 
TTTTTG-3′ 
R 5′-AATTCAAAAAGGACATTCACTGAAATCATCTCTCGAGAGATGATTTCAG 
TGAATGTCC-3′ 
Mus Sam50 
(shSam50) 
F 5′-GATCCCCGAGGAGATGTGAGCTTCATTTCAAGAGAATGAAGCTCACATC 
TCCTCTTTTTGGAAA-3′ 
R 5′-AGCTTTTCCAAAAAGAGGAGATGTGAGCTTCATTCTCTTGAAATGAAGC 
TCACATCTCCTCGGG-3′ 
Homo Metaxin-1 
(shMTX1) 
F5′-CCGGAAGTGGTATGCAGAGGCTATGCTCGAGCATAGCCTCTGCATACCAC 
TTTTTTTG-3′ 
R5′-AATTCAAAAAAAGTGGTATGCAGAGGCTATGCTCGAGCATAGCCTCTGCATA 
CCACTT-3′ 
Homo Metaxin-2 
(shMTX2) 
F 5′-CCGGGGGAAGTCAAACGTAAGATGACTCGAGTCATCTTACGTTTGACTT 
CCCTTTTTG-3 
R 5′-AATTCAAAAAGGGAAGTCAAACGTAAGATGACTCGAGTCATCTTACGTT 
TGACTTCCC-3 
Homo 
VDAC1(shVDAC
1-1) 
F 5′-CCGGAAAGTGACGGGCAGTCTGGAACTCGAGTTCCAGACTGCCCGTCAC 
TTTTTTTTG-3′ 
R 5′-AATTCAAAAAAAAGTGACGGGCAGTCTGGAACTCGAGTTCCAGACTGCC 
CGTCACTTT-3′ 
Homo VDAC1 
(shVDAC1-2) 
F 5′-CCGGCTCCAGGTTAAAGTTGATTCACTCGAGTGAATCAACTTTAACCTG 
GAGTTTTTG-3′ 
R 5′-AATTCAAAAACTCCAGGTTAAAGTTGATTCACTCGAGTGAATCAACTTT 
AACCTGGAG-3′ 
Homo Tom40 
(shTom40-1) 
F 5′-CCGGCAACTGGTTGGCAACGGTATTCTCGAGAATACCGTTGCCAACCAG 
TTGTTTTTG-3′ 
R 5′-AATTCAAAAACAACTGGTTGGCAACGGTATTCTCGAGAATACCGTTGCC 
AACCAGTTG-3′ 
Homo Tom40 
(shTom40-2) 
F 5′-CCGGGGTTGGCAACGGTAACGTTGGCTCGAGCCAACGTTACCGTTGCCA 
ACCTTTTTG-3′ 
R 5′-AATTCAAAAAGGTTGGCAACGGTAACGTTGGCTCGAGCCAACGTTACCG 
TTGCCAACC-3′ 
 
Homo ATG5 
(shATG5) 
F 5′-CCGGCCTTTCATTCAGAAGCTGTTTCTCGAGAAACAGCTTCTGAATGAA 
AGGTTTTTG-3′ 
R 5′-AATTCAAAAACCTTTCATTCAGAAGCTGTTTCTCGAGAAACAGCTTCTGA 
ATGAAAGG-3′ 
Homo OPA1 
(shOPA1) 
F 5′-GATCCCCGTTATCAGTCTGAGCCAGGTTCAAGAGACCTGGCTCAGACTG 
ATAACTTTTTGGAAA-3′ 
R 5′-AGCTTTTCCAAAAAGTTATCAGTCTGAGCCAGGTCTCTTGAACCTGGCTC 
AGACTGATAACGGG-3′ 
Homo Drp1 
(shDrp1) 
F 5′-GATCCCCGAGGTTATTGAACGACTCATTCAAGAGATGAGTCGTTCAATA 
ACCTCTTTTTGGAAA-3′ 
R 5′-AGCTTTTCCAAAAAGAGGTTATTGAACGACTCATCTCTTGAATGAGTCGT 
TCAATAACCTCGGG-3′ 
Homo Mfn1 
(shMfn1) 
F 5′-GATCCCCGATACTAGCTACTGTGAAATTCAAGAGATTTCACAGTAGCTA 
GTATCTTTTTGGAAA-3′ 
R 5′-AGCTTTTCCAAAAAGATACTAGCTACTGTGAAATCTCTTGAATTTCACAG 
TAGCTAGTATCGGG-3′ 
Homo Mfn2 
(shMfn2) 
F 5′-GATCCCCGGAAGAGCACCGTGATCAATTCAAGAGATTGATCACGGTGCT 
CTTCCTTTTTGGAAA-3′ 
R 5′-AGCTTTTCCAAAAAGGAAGAGCACCGTGATCAATCTCTTGAATTGATCA 
CGGTGCTCTTCCGGG-3′ 
Homo Syntaxin17 
(shSyntaxin17-1) 
F5′-CCGGGGTAGTTCTCAGAGTTTGATTCTCGAGAATCAAACTCTGAGAACT 
ACCTTTTTG-3′ 
F5′-AATTCAAAAAGGTAGTTCTCAGAGTTTGATTCTCGAGAATCAAACTCTG 
AGAACTACC-3′ 
Homo Syntaxin17 
(shSyntaxin17-2) 
F5′-CCGGCGATCCAATATCCGAGAAATTCTCGAGAATTTCTCGGATATTGGAT 
CGTTTTTG-3′ 
R5′-AATTCAAAAACGATCCAATATCCGAGAAATTCTCGAGAATTTCTCGGATAT 
TGGATCG-3′ 
Homo Mic60 
(shMic60) 
F5′-GATCCCCGCCCGAATGACTCTAGAAATTCAAGAGATTTCTAGGGTCATT 
CGGGCTTTTTGGAAA-3′ 
F5′-AGCTTTTCCAAAAAGCCCGAATGACCCTAGAAATCTCTTGAATTTCTAGG 
GTCATTCGGGCGGG 
 
 
